210 related articles for article (PubMed ID: 29458327)
21. Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis.
Franco HL; Nagari A; Malladi VS; Li W; Xi Y; Richardson D; Allton KL; Tanaka K; Li J; Murakami S; Keyomarsi K; Bedford MT; Shi X; Li W; Barton MC; Dent SYR; Kraus WL
Genome Res; 2018 Feb; 28(2):159-170. PubMed ID: 29273624
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic Modifications with DZNep, NaBu and SAHA in Luminal and Mesenchymal-like Breast Cancer Subtype Cells.
Dagdemir A; Judes G; Lebert A; Echegut M; Karsli-Ceppioglu S; Rifaï K; Daures M; Ngollo M; Dubois L; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
Cancer Genomics Proteomics; 2016; 13(4):291-303. PubMed ID: 27365379
[TBL] [Abstract][Full Text] [Related]
23. Chromatin Organization and Transcriptional Programming of Breast Cancer Cell Identity.
Bobbitt JR; Seachrist DD; Keri RA
Endocrinology; 2023 Jun; 164(8):. PubMed ID: 37394919
[TBL] [Abstract][Full Text] [Related]
24. H3K27me3 loss plays a vital role in CEMIP mediated carcinogenesis and progression of breast cancer with poor prognosis.
Hsieh IY; He J; Wang L; Lin B; Liang Z; Lu B; Chen W; Lu G; Li F; Lv W; Zhao W; Li J
Biomed Pharmacother; 2020 Mar; 123():109728. PubMed ID: 31846842
[TBL] [Abstract][Full Text] [Related]
25. Histone profiles in cancer.
Riedel SS; Neff T; Bernt KM
Pharmacol Ther; 2015 Oct; 154():87-109. PubMed ID: 26210403
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF7 breast cancer cells.
Sadikovic B; Andrews J; Carter D; Robinson J; Rodenhiser DI
J Biol Chem; 2008 Feb; 283(7):4051-60. PubMed ID: 18065415
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.
Kala R; Shah HN; Martin SL; Tollefsbol TO
BMC Cancer; 2015 Oct; 15():672. PubMed ID: 26459286
[TBL] [Abstract][Full Text] [Related]
28. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.
Amara D; Wolf DM; van 't Veer L; Esserman L; Campbell M; Yau C
Breast Cancer Res Treat; 2017 Jan; 161(1):41-50. PubMed ID: 27815749
[TBL] [Abstract][Full Text] [Related]
29. Transcriptomic and epigenetic analysis of breast cancer stem cells.
Li G; Wang D; Ma W; An K; Liu Z; Wang X; Yang C; Du F; Han X; Chang S; Yu H; Zhang Z; Zhao Z; Zhang Y; Wang J; Sun Y
Epigenomics; 2018 Jun; 10(6):765-783. PubMed ID: 29480027
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
Kar S; Patra SK
Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state.
Lim YY; Wright JA; Attema JL; Gregory PA; Bert AG; Smith E; Thomas D; Lopez AF; Drew PA; Khew-Goodall Y; Goodall GJ
J Cell Sci; 2013 May; 126(Pt 10):2256-66. PubMed ID: 23525011
[TBL] [Abstract][Full Text] [Related]
32. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
M JR; S V
Gene; 2018 Dec; 678():302-311. PubMed ID: 30096458
[TBL] [Abstract][Full Text] [Related]
33. H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes.
Judes G; Dagdemir A; Karsli-Ceppioglu S; Lebert A; Echegut M; Ngollo M; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
Epigenomics; 2016 Jul; 8(7):909-24. PubMed ID: 27424567
[TBL] [Abstract][Full Text] [Related]
34. Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes.
Lomberk G; Blum Y; Nicolle R; Nair A; Gaonkar KS; Marisa L; Mathison A; Sun Z; Yan H; Elarouci N; Armenoult L; Ayadi M; Ordog T; Lee JH; Oliver G; Klee E; Moutardier V; Gayet O; Bian B; Duconseil P; Gilabert M; Bigonnet M; Garcia S; Turrini O; Delpero JR; Giovannini M; Grandval P; Gasmi M; Secq V; De Reyniès A; Dusetti N; Iovanna J; Urrutia R
Nat Commun; 2018 May; 9(1):1978. PubMed ID: 29773832
[TBL] [Abstract][Full Text] [Related]
35. Oncofetal Epigenetic Bivalency in Breast Cancer Cells: H3K4 and H3K27 Tri-Methylation as a Biomarker for Phenotypic Plasticity.
Messier TL; Boyd JR; Gordon JA; Stein JL; Lian JB; Stein GS
J Cell Physiol; 2016 Nov; 231(11):2474-81. PubMed ID: 26916849
[TBL] [Abstract][Full Text] [Related]
36. The histone H2A isoform Hist2h2ac is a novel regulator of proliferation and epithelial-mesenchymal transition in mammary epithelial and in breast cancer cells.
Monteiro FL; Vitorino R; Wang J; Cardoso H; Laranjeira H; Simões J; Caldas M; Henrique R; Amado F; Williams C; Jerónimo C; Helguero LA
Cancer Lett; 2017 Jun; 396():42-52. PubMed ID: 28288875
[TBL] [Abstract][Full Text] [Related]
37. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
Chen H; Lorton B; Gupta V; Shechter D
Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
[TBL] [Abstract][Full Text] [Related]
39. Antioxydation And Cell Migration Genes Are Identified as Potential Therapeutic Targets in Basal-Like and BRCA1 Mutated Breast Cancer Cell Lines.
Privat M; Rudewicz J; Sonnier N; Tamisier C; Ponelle-Chachuat F; Bignon YJ
Int J Med Sci; 2018; 15(1):46-58. PubMed ID: 29333087
[TBL] [Abstract][Full Text] [Related]
40. Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer.
Hon GC; Hawkins RD; Caballero OL; Lo C; Lister R; Pelizzola M; Valsesia A; Ye Z; Kuan S; Edsall LE; Camargo AA; Stevenson BJ; Ecker JR; Bafna V; Strausberg RL; Simpson AJ; Ren B
Genome Res; 2012 Feb; 22(2):246-58. PubMed ID: 22156296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
